Systematic review of trends in prophylaxis of corticosteroid-induced osteoporosis: The need for standard audit guidelines

Osteoporosis International

Volumn 19, Issue 10, 2008, Pages 1379-1394

  Duyvendak, M ^a,b   Naunton, M ^c   Van Roon, E N ^a,d,e   Bruyn, G A W ^e   Brouwers, J R B J ^a,d,e  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b Antonius Hospital Sneek   (Netherlands)

^c CHARLES DARWIN UNIVERSITY   (Australia)

^d Tjongerschans Hospital   (Netherlands)

^e MEDICAL CENTER LEEUWARDEN   (Netherlands)

Author keywords

Bisphosphonates; Corticosteroid; Guideline adherence; Osteoporosis; Prophylaxis; Study quality

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCITRIOL; CALCIUM; CORTICOSTEROID; ETIDRONIC ACID; FLUORIDE; MULTIVITAMIN; PREDNISOLONE; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; VITAMIN D;

BONE DENSITY; CLINICAL TRIAL; CORTICOSTEROID INDUCED OSTEOPOROSIS; DRUG MEGADOSE; HORMONE SUBSTITUTION; HUMAN; LINEAR REGRESSION ANALYSIS; MEDICAL AUDIT; MEDICAL LITERATURE; MEDLINE; MULTIVARIATE ANALYSIS; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PROPHYLAXIS; PUBLICATION; QUALITY CONTROL; REVIEW; STANDARD; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

BONE DENSITY CONSERVATION AGENTS; FEMALE; GLUCOCORTICOIDS; GUIDELINE ADHERENCE; HUMANS; MALE; MEDICAL AUDIT; OSTEOPOROSIS; PRACTICE GUIDELINES AS TOPIC; TREATMENT OUTCOME;

EID: 51249090119     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-008-0598-y     Document Type: Review

References (77)

1. LJ Walsh CA Wong M Pringle AE Tattersfield 1996 Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross-sectional study BMJ 313 344 346
2. TP Staa van HGM Leufkens L Abenhaim B Begaud B Zhang C Cooper 2000 Use of oral corticosteroids in the United Kingdom QJM 93 105 111
3. TP Staa van HGM Leufkens L Abenhaim C Cooper 2000 Use of oral corticosteroids and risk of fractures J Bone Miner Res 15 993 1000
4. C Gennari 1994 Glucocorticoid induced osteoporosis Clin Endocrinol (Oxf) 41 273 274
5. PJ Rackoff CJ Rosen 1998 Pathogenesis and treatment of glucocorticoid-induced osteoporosis Drugs Aging 12 477 484
6. RA Yood 2006 Prevention of glucocorticoid-induced osteoporosis: why are we doing so poorly? J Rheumatol 33 1461 1463
7. R Bell A Carr P Thompson 1997 Managing corticosteroid induced osteoporosis in medical outpatients J R Coll Physicians Lond 31 158 161
8. LM Buckley M Marquez R Feezor DM Ruffin LL Benson 1999 Prevention of corticosteroid-induced osteoporosis: results of a patient survey Arthritis Rheum 42 1736 1739
9. I Chattopadhyay AR Showkathali AK Jain 2002 Osteoporosis prophylaxis during corticosteroid treatment Postgrad Med J 78 572
10. JR Curtis AO Westfall JJ Allison A Becker L Casebeer A Freeman CM Spettell NW Weissman S Wilke KG Saag 2005 Longitudinal patterns in the prevention of osteoporosis in glucocorticoid-treated patients Arthritis Rheum 52 2485 2494
11. AL Dolan E Koshy M Waker CM Goble 2004 Access to bone densitometry increases general practitioners' prescribing for osteoporosis in steroid treated patients Ann Rheum Dis 63 183 186
12. ME Elliott RM Farrah NC Binkley ML Carnes A Gudmundsson 2000 Management of glucocorticoid-induced osteoporosis in male veterans Ann Pharmacother 34 1380 1384
13. N Erb RC Duncan K Raza IF Rowe GD Kitas RD Situnayake 2002 A regional audit of the prevention and treatment of corticosteroid-induced osteoporosis in patients with rheumatic diseases in the West Midlands Rheumatology (Oxford) 41 1021 1024
14. B Ettinger P Chidambaran A Pressman 2001 Prevalence and determinants of osteoporosis drug prescription among patients with high exposure to glucocorticoid drugs Am J Manag Care 7 597 605
15. Feldstein AC, Elmer PJ, Nichols GA, Herson M. Practice patterns in patients at risk for glucocorticoid-induced osteoporosis. Osteoporos Int 2005
16. SR Hart B Green 2002 Osteoporosis prophylaxis during corticosteroid treatment: failure to prescribe Postgrad Med J 78 242 243
17. DM Hougardy GM Peterson MD Bleasel CT Randall 2000 Is enough attention being given to the adverse effects of corticosteroid therapy? J Clin Pharm Ther 25 227 234
18. SJ Lewis PE Smith 2001 Osteoporosis prevention in myasthenia gravis: a reminder Acta Neurol Scand 103 320 322
19. DA Lozsadi G Peters HY Sadik MW Kellett SH Fox DF Smith 2006 Prevention of osteoporosis in glucocorticoid-treated neurology patients Clin Neurol Neurosurg 108 157 162
20. A Mudano J Allison J Hill T Rothermel K Saag 2001 Variations in glucocorticoid induced osteoporosis prevention in a managed care cohort J Rheumatol 28 1298 1305
21. V Naganathan P Sambrook 2001 Osteoporosis and fracture risk prevention in long-term glucocorticoid therapy, authors reply Arch Intern Med 161 1781
22. M Naunton GM Peterson G Jones GM Griffin MD Bleasel 2004 Multifaceted educational program increases prescribing of preventive medication for corticosteroid induced osteoporosis J Rheumatol 31 550 556
23. M Osiri KG Saag AM Ford LW Moreland 2000 Practice pattern variation among internal medicine specialists in the prevention of glucocorticoid-induced osteoporosis J Clin Rheumatol 6 117 122
24. AD Rothberg PK Matshidze 2000 Monitoring and management of bone status in patients on chronic glucocorticoid treatment-the Medscheme experience S Afr Med J 90 1125 1129
25. KG Saag SH Gehlbach JR Curtis TE Youket K Worley JL Lange 2006 Trends in prevention of glucocorticoid-induced osteoporosis J Rheumatol 33 1651 1657
26. GD Smith DL Stevens GN Fuller 2001 Myasthenia gravis, corticosteroids and osteoporosis prophylaxis J Neurol 248 151
27. DH Solomon JN Katz JP Jacobs AM La Tourette J Coblyn 2002 Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: rates and predictors of care in an academic rheumatology practice Arthritis Rheum 46 3136 3142
28. DH Solomon JN Katz D Cabral AR Patrick JF Bukowski JS Coblyn 2006 Osteoporosis management in patients with rheumatoid arthritis: Evidence for improvement Arthritis Rheum 55 873 877
29. K Walker-Bone A Wood R Hull JM Ledingham FC McCrae R Shaban A Thomas K Mackay 2004 The prevention and treatment of glucocorticoid-induced osteoporosis in clinical practice Clin Med 4 431 436
30. EM Aagaard P Lin GW Modin NE Lane 1999 Prevention of glucocorticoid- induced osteoporosis: provider practice at an urban county hospital Am J Med 107 456 460
31. IW Chantler MW Davie SF Evans JS Rees 2003 Oral corticosteroid prescribing in women over 50, use of fracture prevention therapy, and bone densitometry service Ann Rheum Dis 62 350 352
32. LM Cruse J Valeriano FB Vasey JD Carter 2006 Prevalence of evaluation and treatment of glucocorticoid-induced osteoporosis in men J Clin Rheumatol 12 221 225
33. B Gudbjornsson UI Juliusson FV Gudjonsson 2002 Prevalence of long term steroid treatment and the frequency of decision making to prevent steroid induced osteoporosis in daily clinical practice Ann Rheum Dis 61 32 36
34. PR Hodgkins RG Hull A Vakalis A Cole C Hallet AR Evans MN Jeffrey 1997 Long-term oral corticosteroids and osteoporosis prevention in an ophthalmology clinic Eye 11 Pt 1 126 127
35. E Karcic AA Karcic 2001 Osteoporosis and fracture risk prevention in long-term glucocorticoid therapy Arch Intern Med 161 1780 1781
36. RH Liu J Albrecht VP Werth 2006 Cross-sectional study of bisphosphonate use in dermatology patients receiving long-term oral corticosteroid therapy Arch Dermatol 142 37 41
37. RP McDonough WR Doucette P Kumbera DG Klepser 2005 An evaluation of managing and educating patients on the risk of glucocorticoid-induced osteoporosis Value Health 8 24 31
38. S Miah R Taylor G McKellar J Hunter 2003 Corticosteroid-induced osteoporosis Rheumatology (Oxford) 42 1118 1120
39. C Olesen HT Sorensen FH Steffensen GL Nielsen J Olsen 1996 Danish data confirm low prevalence of HRT among women prescribed oral corticosteroids BMJ 313 1264
40. ID Peat S Healy DM Reid SH Ralston 1995 Steroid induced osteoporosis: an opportunity for prevention? Ann Rheum Dis 54 66 68
41. MD Smith SP Cheah K Taylor MJ Ahern 2001 Prevention of corticosteroid induced osteoporosis in inpatients recently discharged from a tertiary teaching hospital J Rheumatol 28 566 570
42. DH Solomon JN Katz AM La Tourette JS Coblyn 2004 Multifaceted intervention to improve rheumatologists' management of glucocorticoid-induced osteoporosis: a randomized controlled trial Arthritis Rheum 51 383 387
43. RA Yood LR Harrold L Fish J Cernieux S Emani E Conboy JH Gurwitz 2001 Prevention of glucocorticoid-induced osteoporosis: experience in a managed care setting Arch Intern Med 161 1322 1327
44. R Eastell 1995 Management of corticosteroid-induced osteoporosis. UK Consensus Group Meeting on Osteoporosis J Intern Med 237 439 447
45. American College of Rheumatology Ad Hoc Committee on Glucocorticoid- Induced Osteoporosis 1996 Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. American College of Rheumatology Task Force on Osteoporosis Guidelines Arthritis Rheum 39 1791 1801
46. American College of Rheumatology Ad Hoc Committee on Glucocorticoid- Induced Osteoporosis 2001 Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis Arthritis Rheum 44 1496 1503
47. PN Sambrook T Diamond L Ferris M Fiatarone-Singh L Flicker A MacLennan C Nowson S O'Neill H Greville 2001 Corticosteroid induced osteoporosis. Guidelines for treatment Aust Fam Physician 30 793 796
48. JP Devogelaer S Goemaere S Boonen JJ Body JM Kaufman JY Reginster S Rozenberg Y Boutsen 2006 Evidence-based guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis: a consensus document of the Belgian Bone Club Osteoporos Int 17 8 19
49. RNJ de Nijs JWJ Bijlsma P Geusens RFJM Laan WF Lems A Struijs TP van Staa 2002 Round table meeting: Prevention and treatment of glucocorticosteroid induced osteoporosis Ned Tijdschr Rheumatol 1 12 17
50. HAPP Pols J Wittenberg 2002 CBO-guideline osteoporosis (second revision) Ned Tijdschr Geneeskd 146 1359 1363
51. T Diamond L McGuigan S Barbagallo C Bryant 1995 Cyclical etidronate plus ergocalciferol prevents glucocorticoid-induced bone loss in postmenopausal women Am J Med 98 459 463
52. A Struys AA Snelder H Mulder 1995 Cyclical etidronate reverses bone loss of the spine and proximal femur in patients with established corticosteroid-induced osteoporosis Am J Med 99 235 242
53. H Mulder A Struys 1994 Intermittent cyclical etidronate in the prevention of corticosteroid-induced bone loss Br J Rheumatol 33 348 350
54. SJ Skingle AJ Crisp 1994 Increased bone density in patients on steroids with etidronate Lancet 344 543 544
55. J Adachi A Cranney CH Goldsmith WG Bensen F Bianchi A Cividino GL Craig E Kaminska RJ Sebaldt A Papaioannou 1994 Intermittent cyclic therapy with etidronate in the prevention of corticosteroid induced bone loss J Rheumatol 21 1922 1926
56. KG Saag R Emkey TJ Schnitzer JP Brown F Hawkins S Goemaere G Thamsborg UA Liberman PD Delmas MP Malice M Czachur AG Daifotis 1998 Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group N Engl J Med 339 292 299
57. DM Reid RA Hughes RF Laan NA Sacco-Gibson DH Wenderoth S Adami RA Eusebio JP Devogelaer 2000 Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: a randomized trial. European Corticosteroid-Induced Osteoporosis Treatment Study J Bone Miner Res 15 1006 1013
58. JD Adachi KG Saag PD Delmas UA Liberman RD Emkey E Seeman NE Lane JM Kaufman PE Poubelle F Hawkins R Correa-Rotter CJ Menkes JA Rodriguez-Portales TJ Schnitzer JA Block J Wing HH McIlwain R Westhovens J Brown JA Melo-Gomes BL Gruber MJ Yanover MO Leite KG Siminoski MC Nevitt JT Sharp MP Malice T Dumortier M Czachur W Carofano A Daifotis 2001 Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled extension trial Arthritis Rheum 44 202 211
59. Merck Sharpe & Dohme. Registration of Alendronate for GIOP. 2006
60. Proctor & Gamble. Registration of Risedronate for GIOP. 2006
61. F de Vries S Pouwels JW Lammers HG Leufkens M Bracke C Cooper TP van Staa 2007 Use of inhaled and oral glucocorticoids, severity of inflammatory disease and risk of hip/femur fracture: a population-based case-control study J Intern Med 261 170 177
62. JM Pettifor 2000 Chronic glucocorticoid therapy and osteoporosis-an under-recognised problem in South Africa S Afr Med J 90 1111 1112
63. JS McCombs P Thiebaud C McLaughlin-Miley J Shi 2004 Compliance with drug therapies for the treatment and prevention of osteoporosis Maturitas 48 271 287
64. DH Solomon J Avorn JN Katz JS Finkelstein M Arnold JM Polinski MA Brookhart 2005 Compliance with osteoporosis medications Arch Intern Med 165 2414 2419
65. M Naunton M Duyvendak GM Peterson JR Brouwers 2006 Practice patterns in osteoporosis prevention in patients on glucocorticoids Osteoporos Int 17 634 635
66. GM Kiebzak GA Beinart K Perser CG Ambrose SJ Siff MH Heggeness 2002 Undertreatment of osteoporosis in men with hip fracture Arch Intern Med 162 2217 2222
67. BM Kuehn 2006 Reports of adverse events from bone drugs prompt caution JAMA 295 2833 2836
68. SB Woo JW Hellstein JR Kalmar 2006 Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws Ann Intern Med 144 753 761
69. M Naunton 2006 Is the increase in osteoporosis prevention a result of the audit? Clin Neurol Neurosurg 108 718 719
70. RP Grol MC Bosch ME Hulscher MP Eccles M Wensing 2007 Planning and studying improvement in patient care: the use of theoretical perspectives Milbank Q 85 93 138
71. H Wollersheim J Burgers R Grol 2005 Clinical guidelines to improve patient care Neth J Med 63 188 192
72. R Eastell DM Reid J Compston C Cooper I Fogelman RM Francis DJ Hosking DW Purdie SH Ralston J Reeve RG Russell JC Stevenson DJ Torgerson 1998 A UK Consensus Group on management of glucocorticoid-induced osteoporosis: an update J Intern Med 244 271 292
73. National Osteoporosis Society (1998) Guidance on the prevention and management of corticosteroid induced osteoporosis. National Osteoporosis Society, Bath, UK
74. Royal College of Physicians (1999) Osteoporosis: Clinical guidelines for prevention and treatment. Royal College of Physicians, London, UK
75. S Hough 2000 Osteoporosis Clinical Guideline. South African Medical Association-Osteoporosis Working Group S Afr Med J 90 907 944
76. Dolan AL (2007) Greenwich and Bexley guidelines for identification, assessment and management of osteoporosis. Greenwich
77. Bone and Tooth Society, Royal College of Physicians, National Osteoporosis Society (2002) Glucocorticoid-induced osteoporosis: guidelines for prevention and treatment. Royal College of Physicians, London, UK